NSE filing, NSE: MONOPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Mono Pharmacare Ltd: key numbers
- Share price
- ₹9.30
- Market cap
- ₹16.43 Cr
- Revenue (annual)
- ₹165.7 Cr
- Net profit (annual)
- ₹0.73 Cr
- P/E (TTM)
- 22.4×Sector 46.1×
- Promoter holding
- 56.72%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mono Pharmacare Ltd
All →Mono Pharmacare Other Announcement
Mono Pharmacare declares non-applicability of the Regulation 27(2) corporate governance report for Q2 FY2026-27, as its shares are SME-listed. The filing is a routine compliance exemption notice with no business event.
Mono Pharmacare Other Announcement
Mono Pharmacare notified non-applicability of its Q1 FY27 corporate governance report under Reg 27(2). As an SME-listed entity, it is exempt under Reg 15(2)(b) of SEBI LODR.
Mono Pharmacare Annual General Meeting
Mono Pharmacare Limited held its Annual General Meeting on September 30, 2026. Shareholders approved financial statements, director re-appointment, auditor appointment, and related party transactions.
Mono Pharmacare Annual General Meeting
Mono Pharmacare Limited has fixed September 23, 2026, as the record date for remote e-voting eligibility for its Annual General Meeting.
Mono Pharmacare Legal & Regulatory
Mono Pharmacare received NSE fines totaling Rs. 0.02 Crore for non-compliance with SEBI Regulations 33 and 76. The Board has advised strengthening the company's compliance mechanism.
- Value
- ₹0.02 Cr
Mono Pharmacare Annual General Meeting
Mono Pharmacare Limited has issued a notice for its 4th Annual General Meeting scheduled for September 30, 2026, at its registered office in Ahmedabad.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.